100 , S3S5 (1997)
Heterogeneity in response to GLP-1 receptor agonists in type 2 diabetes in real-world clinical practice: insights from the DPV register an IMI-SOPHIA study
Heterogeneities were evaluated both within and between study designs across America (I 2 = 0.0%, p = 0.592), Asia (I 2 = 96.2%, p = 0.000), Europe (I 2 = 63.6%, p = 0.017), and overall (I 2 = 83.6%, p = 0.000) (Fig
A mature biofilm means longer filter runs, fewer media replacements, and greater stabilitybe patient during acclimation
How it works: For less than $1 a day, you get weekly meal plans with over 30 recipes
We're seeing an increasing sophistication in metabolic research, with a greater emphasis on personalized protocols and deeper mechanistic understanding